Philipp R Esser1, Stefan F Martin2. 1. Klinik für Dermatologie und Venerologie, Forschergruppe Allergologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Hauptstr. 7, 79104, Freiburg im Breisgau, Deutschland. philipp.esser@uniklinik-freiburg.de. 2. Klinik für Dermatologie und Venerologie, Forschergruppe Allergologie, Universitätsklinikum Freiburg, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Hauptstr. 7, 79104, Freiburg im Breisgau, Deutschland. stefan.Martin@uniklinik-freiburg.de.
Abstract
BACKGROUND: While the pathogenesis of contact allergy in recent years has increasingly focused on the mechanisms of the innate immune response, valid therapeutic options are still lacking. AIMS: This article intends to shed light on the background of contact allergy development as well as possible risk factors and to highlight potential new therapeutic options. MATERIALS AND METHODS: Allergic contact dermatitis (ACD) as well as the sensitization and trigger phase, potential risk factors as well as the therapy options including (current) PubMed-listed literature are described. RESULTS: Inflammation plays a central role in ACD. The innate immune system responds to contact allergens as well as to infection. Elucidation of the mechanisms will enable a targeted therapeutic intervention in the future. CONCLUSION: Although there is still a need for research, many parts of the contact allergy pathogenesis are now better understood. In particular, the essential role of the innate immune response not only for the sensitization but also for the elicitation phase seems to be established. Implementation of today's knowledge into new therapeutic approaches and their application testing remains important and exciting.
BACKGROUND: While the pathogenesis of contact allergy in recent years has increasingly focused on the mechanisms of the innate immune response, valid therapeutic options are still lacking. AIMS: This article intends to shed light on the background of contact allergy development as well as possible risk factors and to highlight potential new therapeutic options. MATERIALS AND METHODS:Allergic contact dermatitis (ACD) as well as the sensitization and trigger phase, potential risk factors as well as the therapy options including (current) PubMed-listed literature are described. RESULTS: Inflammation plays a central role in ACD. The innate immune system responds to contact allergens as well as to infection. Elucidation of the mechanisms will enable a targeted therapeutic intervention in the future. CONCLUSION: Although there is still a need for research, many parts of the contact allergy pathogenesis are now better understood. In particular, the essential role of the innate immune response not only for the sensitization but also for the elicitation phase seems to be established. Implementation of today's knowledge into new therapeutic approaches and their application testing remains important and exciting.
Authors: Magnus David Lynch; John Paul McFadden; Jonathan Michael White; Piu Banerjee; Ian Richard White Journal: J Allergy Clin Immunol Date: 2017-06-09 Impact factor: 10.793
Authors: Badrinarayanan Raghavan; Stefan F Martin; Philipp R Esser; Matthias Goebeler; Marc Schmidt Journal: EMBO Rep Date: 2012-10-12 Impact factor: 8.807
Authors: Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers Journal: Immunity Date: 2011-06-24 Impact factor: 31.745
Authors: B Blömeke; R Brans; H Dickel; T Bruckner; S Erdmann; M Heesen; H F Merk; P-J Coenraads Journal: Allergy Date: 2008-03-29 Impact factor: 13.146
Authors: Felix C Weber; Philipp R Esser; Tobias Müller; Jayanthi Ganesan; Patrizia Pellegatti; Markus M Simon; Robert Zeiser; Marco Idzko; Thilo Jakob; Stefan F Martin Journal: J Exp Med Date: 2010-11-08 Impact factor: 14.307
Authors: Jochen Brasch; Detlef Becker; Werner Aberer; Andreas Bircher; Birger Kränke; Kirsten Jung; Bernhard Przybilla; Tilo Biedermann; Thomas Werfel; Swen Malte John; Peter Elsner; Thomas Diepgen; Axel Trautmann; Hans F Merk; Thomas Fuchs; Axel Schnuch Journal: Allergo J Int Date: 2014
Authors: Felix C Weber; Tamás Németh; Janka Z Csepregi; Anne Dudeck; Axel Roers; Béla Ozsvári; Eva Oswald; László G Puskás; Thilo Jakob; Attila Mócsai; Stefan F Martin Journal: J Exp Med Date: 2014-12-15 Impact factor: 14.307
Authors: Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg Journal: J Exp Med Date: 2008-08-25 Impact factor: 14.307